Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies [Phase 2]
Phase II trial of APL-2 in glomerulopathies completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of Felzartamab (MOR202) in immunoglobulin A nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy [Phase 2]
This update notes the completion of a Phase 2 study evaluating IONIS-FB-LRx for primary IgA nephropathy, assessing its effectiveness and saf…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) [Phase 3]
A Phase 3 extension update reporting efficacy and safety outcomes for patients with primary IgA nephropathy who completed the NEF-301 study …
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: Efficacy and Safety of Telitacicept in IgAN [NA]
Clinical trial update on the efficacy and safety of Telitacicept for IgA nephropathy; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy [Phase 3]
Phase 3 trial update for Nefecon in adults with primary IgA nephropathy reports efficacy and safety outcomes; results have been posted follo…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Atrasentan in Patients With IgA Nephropathy [Phase 3]
Phase 3 clinical trial update for atrasentan in IgA nephropathy; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy [Phase 2]
A Phase 2 study of RC18 administered subcutaneously to subjects with primary IgA nephropathy has been completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN
This update reports the completion of a replication trial evaluating TRF-budesonide for IgA nephropathy. The results are not provided in the…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy [Phase 4]
Phase 4 clinical trial is evaluating the efficacy and safety of a combination of probiotics with enteric-coated budesonide capsules in patie…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy [Phase 3]
Phase 3 study evaluating sparsentan for IgA nephropathy has posted results in July 2024; the trial is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
This document reports the completion of a clinical trial evaluating the efficacy and safety of finerenone for treating IgA nephropathy.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN) [Phase 2]
The Phase 2 trial of cemdisiran in adults with immunoglobulin A nephropathy (IgAN) has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy [Phase 4]
A randomized, controlled Phase 4 trial evaluating rituximab for treatment of IgA nephropathy is underway, with status not specified.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Study of Telitacicept in Patients With Refractory IgA Nephropathy [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update for telitacicept in refractory IgA nephropathy; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation [Phase 2]
Phase 2 trial update on safety and efficacy of LNP023 in IgA nephropathy has been completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy [Phase 2]
Phase 2 trial of AVB-S6-500 in IgA nephropathy was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX [Phase 2]
Phase 2 trial evaluating bardoxolone methyl in rare chronic kidney diseases has completed, with results posted January 18, 2022. Diseases st…
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy [Phase 2, Phase 3]
Clinical trial update for plasma exchange in severe crescentic IgA nephropathy indicates termination after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Steroids Therapy in IgA Nephropathy With Crescents [Phase 3]
Phase 3 trial update investigating steroid therapy for IgA nephropathy with crescents.
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: Efficacy and Safety of Atacicept in IgA Nephropathy [Phase 2]
Phase 2 trial of atacicept in IgA nephropathy was terminated with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment [Phase 4]
Phase 4 trial updating prevention of recurrence after kidney transplantation in IgA nephropathy comparing ATG-F versus Basiliximab induction…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency [Phase 4]
A Phase 4 clinical trial evaluating leflunomide plus low-dose corticosteroid in IgA nephropathy with renal insufficiency.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) [Phase 3]
Phase 3 trial update on mycophenolate mofetil (MMF) for IgA nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy [Phase 2]
Phase 2 clinical trial update for fostamatinib in IgA nephropathy reports safety and efficacy data.